Multicenter, Single-arm, Open-label Extension Study to Assess Long-term Safety and Efficacy of Current or Prior Treatment with Denosumab in Children/Young Adults with Osteogenesis Imperfecta
-
- STATUS
- Not Recruiting
Updated on 19 February 2024
Summary
This study 20170534 is an open-label extension of study 20130173 to assess long-term safety and efficacy of current or prior treatment with denosumab in children/young adults with osteogenesis imperfecta (OI).
Details
| Condition | Osteogenesis Imperfecta |
|---|---|
| Age | 100years or below |
| Clinical Study Identifier | TX10148 |
| Last Modified on | 19 February 2024 |
How understandable was the trial content above?
Hard to understand
Easy to understand
Similar trials to consider
Loading...
Not finding what you're looking for?
Sign up as a volunteer to stay informed
Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.
Sign up as volunteerStudy Definition
WikipediaAdd a private note
- Select a piece of text.
- Add notes visible only to you.
- Send it to people through a passcode protected link.